Experimental pill nearly doubles survival time for people with advanced pancreatic cancer. ‘I actually started crying’
Fortune
—
The drug is called daraxonrasib and it blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases — a target that had eluded treatment for decades.
Pancreatic Cancer Pill Doubles Survival
- Pancreatic cancers: New drug doubles survival rate as France rolls out prevention program Le Monde —
- Revolution Medicines reports Phase 3 win in pancreatic cancer Seeking Alpha —
- New drug nearly doubles survival rates in some pancreatic cancer patients, study says CBS News —
- New drug offers ‘large step forward’ to treat advanced pancreatic cancer al.com —
- Why this new pill for a deadly cancer has doctors excited The i Paper —